May
30
Wed
Medicine Grand Rounds: Theranostics: The tale of a rare tumor, a receptor, and the FDA @ LKSC, Berg Hall
May 30 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Theranostics: The tale of a rare tumor, a receptor, and the FDA @ LKSC, Berg Hall | Palo Alto | California | United States

Presenter: Pamela Kunz, MD
Assistant Professor of Oncology
Stanford University

Pamela Kunz, MD, specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors (NETs). She has developed broad investigative programs in the field of neuroendocrine tumors, encompassing clinical trials, population sciences, and translational correlates. She is the Principal Investigator on numerous clinical trials. She is the Director of the Stanford Neuroendocrine Tumor Program. She currently serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel, the Neuroendocrine Tumor Taskforce of the National Cancer institute, the NANETS Guidelines and Executive Committees, and leads the NET Working Group of the Eastern Cooperative Oncology Group (ECOG).